Table 5.
Testing parameter | Disorders |
---|---|
Creatine phosphokinase (Serum) |
Muscular dystrophies Merosin deficient congenital muscular dystrophy Dystroglycanopathies |
Lactate, pyruvate (Plasma, Cerebrospinal fluid) | Mitochondrial disorders |
Glycosaminoglycans (Urine) | Metachromatic leukodystrophy Multiple sulfatase deficiency |
Organic acids (Urine) | L-2-hydroxyglutarate N-acetylaspartic acid for Canavan disease Metabolic disorders of Krebs cycle Other mitochondrial disorders |
Amino acids (Urine) | Aminoacidopathies Maple syrup urine disease Homocystinuria Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome Pyruvate dehydrogenase complex deficiency |
Very long chain fatty acids (Plasma) | Peroxisomal disorders X-linked adrenoleukodystrophy |
Lysosomal enzymes (leukocytes/fibroblasts) | Krabbe (galactosyl cerebrosidase) Metachromatic leukodystrophy (arylsulfatase A) Multiple sulfatase deȴciency (arylsulfatase A,B,C,D) GM1 gangliosidosis (beta galactosidase) GM2 gangliosidosis (hexosaminidase A & B) Sialidosis (neuraminidase) Galactosialidosis (neuraminidase and beta galactosidase) |
1,4-alpha-glucan-branching enzyme activity | Adult polyglucosan body disease |
Cholestanol | Cerebrotendinous xanthomatosis |
Fatty aldehyde dehydrogenase enzyme | Sjogren-Larsson syndrome |